523. Reducing in Vivo Clearance of Lentiviral Vectors by Immune Cells in Order to Improve Efficacy and Safety of Gene Therapy

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)34858-4
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Shuttle of Lentiviral Vectors via Transplanted Cells in Vivo

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2004English

Development of Gene Therapy for Hematopoietic Stem Cells Using Lentiviral Vectors

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2002English

Lentiviral Vectors Mediate Efficient and Stable Gene Transfer in Adult Neural Stem Cells in Vivo

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2006English

Lentiviral Gene Therapy Vectors: Challenges and Future Directions

2013English

59. Developing Lentiviral Vectors for Targeted Gene Delivery in Vivo

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Adult Rat Liver Cells Transdifferentiated With Lentiviral IPF1 Vectors Reverse Diabetes in Mice: An Ex Vivo Gene Therapy Approach

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2006English

Safety and Early Efficacy Outcomes for Lentiviral Fibroblast Gene Therapy in Recessive Dystrophic Epidermolysis Bullosa

JCI insight
Medicine
2019English

Lentiviral Interleukin-10 Gene Therapy: Safety and Questions

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

531. Designing Trans-Regulated Lentiviral Vectors for Gene Transfer in Functional Genomics and Gene Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy